Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
16 April 2010
IN THIS ISSUE
Plugging pipelines
The promise of cures
Prescription drug user fees
USP structure and goals
PTE on LinkedIn
 
Orphan drugs to plug pipeline gaps
Orphan drugs may help pharma companies to reduce the impact of revenue loss caused by patent expiries of blockbuster drugs, according to market analysts Frost & Sullivan. More...
 
Regenerative medicine promises cures
Regenerative medicine has been described as holding the "promise of cures" by speakers at the first annual Translational Regenerative Medicine Forum, which was held last week in the US. More...
 
FDA holds public meeting on Prescription Drug User Fee Act
The FDA has held a public meeting to solicit stakeholders’ comments about the Prescription Drug User Fee Act (PDUFA) program, which authorizes user fees that help the agency ensure a predictable and efficient drug-review process. More...
 
USP convention to reshape organizational structure and goals
Next week, the United States Pharmacopeial Convention (USP) will hold its governance meeting in Washington, DC (USA) where convention delegates will set and revise policy and operational direction for the organization for the coming 5 years. The meeting only takes place every 5 years. More...
 
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile
Agilent
The Agilent 2100 Bioanalyzer plus the Agilent High Sensitivity Protein 250 Kit automatically detects and quantifies protein impurities down to 0.05% for superior Protein QC in a production-ready method!
Read more...

Product Profile
Agilent
Poroshell 120 HPLC columns give you speed and resolution like a sub-2 µm column with up to 50% less back pressure – usually less than 400 bar. And they have standard frits, so they are more forgiving for dirty samples.
Read more...

Product Profile
Shimadzu
Shimadzu has introduced the Nexera ultra high-performance liquid chromatography (UHPLC) system. The LC-30A Nexera is unsurpassed in high-speed and high-resolution analysis and productivity. It meets the needs of the most demanding markets such as pharmaceutical and the food industry.
Read more...

Key Topic Updates
Latest blog posts
In the name of accountability
Appearing live at the Javits Center
If it seems too good to be true
More blog posts

April events
Technopharm 2010 (27–29 April | Germany)
LogiPharma 2010 (27–29 April | Switzerland)
Advances and opportunities in Controlled Release (28–29 April | UK)
More events

Latest articles
The personalized medicine marathon
Reduced method robustness testing of analytical methods driven by a risk-based approach
Quality management systems for small organizations: Reducing the headache
More articles

Key Topic Updates

Survey
How do you think the recently passed US healthcare reform law will affect the pharma and biopharma industries?
  Benefit the pharmaceutical and biotechnology industries 38%
  Hurt the pharmaceutical and biotechnology industries 32%
  Have no impact on the pharmaceutical and biotechnology industries 5%
  Don’t know what the implications to the pharmaceutical and biotechnology industries will be 25%

This week we would like to know...

For what reason is your manufacturing facility purchasing more equipment?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected]or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.